Sage Journals: Discover world-class research

Retricted access

Research article

First published 2007-06

Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with 177 Lu DOTA-TATE and 177 Lu DOTA-NOC

Christiane Wehrmann, Stefan Senftleben, Carolin Zachert [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2019-1

Safety Study of Single-Dose Intravenously Administered DOTA-Siglec-9 Peptide in Sprague Dawley Rats

Paulina Chrusciel, Emrah Yatkin, Xiang-Guo Li [...]

International Journal of Toxicology

Retricted access

Research article

First published 2006-04

A Phase I Trial of 90 Y-DOTA-Anti-CEA Chimeric T84.66 (cT84.66) Radioimmunotherapy in Patients with Metastatic CEA-Producing Malignancies

Jeffrey Y.C. Wong, David Z. Chu, Lawrence E. Williams [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2020-10

Impact of DOTA-Chelators on the Antitumor Activity of 177 Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice

Wioletta Wojdowska, Urszula Karczmarczyk, Lajos Balog [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2020-12

Watch to win? E-sport,broadcast expertise and technicity in Dota 2

Ben Egliston

Convergence: The International Journal of Research into New Media Technologies

Retricted access

Review article

First published 2021-9

Clinical value of 68 Ga-DOTA-SSTR PET/CT in the diagnosis and detection of neuroendocrine tumors of unknown primary origin: a systematic review and meta-analysis

Huan Ma, Ying Kan, Ji-gang Yang

Acta Radiologica

Retricted access

Research article

First published 2003-08

Biodistribution and Dosimetry of 177 Lu-Labeled [DOTA 0,Tyr 3 ]Octreotate in Male Nude Mice with Human Small Cell Lung Cancer

Anneli Schmitt, Peter Bernhardt, Ola Nilsson [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2021-10

Preclinical PET Imaging of NTSR-1-Positive Tumors with 64 Cu- and 68 Ga-DOTA-Neurotensin Analogs and Therapy with an 225 Ac-DOTA-Neurotensin Analog

Daneng Li, Megan Minnix, Rebecca Allen [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2008-02

Comparison of [ 177 Lu-DOTA 0,Tyr 3 ]-Octreotate and [ 177 Lu-DOTA 0,Tyr 3 ]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1

Christina Swärd, Peter Bernhardt, Viktor Johanson [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-08

Is the Renal Dosimetry for [ 90 Y-DOTA 0,Tyr 3 ]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

Mark W. Konijnenberg

Cancer Biotherapy and Radiopharmaceuticals

Search results